SCHEMBL30320388

SCHEMBL30320388

COC(=O)c1ccc(OCc2ccccn2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.69
MAPT P10636 5/20 0.59
KDM4E B2RXH2 2/20 0.59
POLB P06746 1/20 0.59
RAB9A P51151 3/20 0.59
SMN1; SMN2 Q16637 4/20 0.56
ALDH1A1 P00352 1/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
PKM P14618 1/20 0.56
NPC1 O15118 2/20 0.55
MAPK14 Q16539 3/20 0.54
SMO Q99835 3/20 0.54
LMNA P02545 1/20 0.52
HPGD P15428 1/20 0.52
HSD17B10 Q99714 1/20 0.52
SYK P43405 1/20 0.52
AURKB Q96GD4 1/20 0.52
INCENP Q9NQS7 1/20 0.52
TDP1 Q9NUW8 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1732629 1.00 PARP10 (0.69) PARP10MAPTKDM4EPOLBRAB9A
SCHEMBL12356722 0.91 PARP10 (0.59) PARP10MAPTKDM4EPOLBRAB9A
SCHEMBL14562689 0.89 PARP10 (0.56) PARP10MAPTKDM4EPOLBRAB9A
SCHEMBL12356701 0.88 PARP10 (0.55) PARP10MAPTKDM4EPOLBRAB9A
SCHEMBL2250280 0.88 PARP10 (0.55) PARP10MAPTKDM4EPOLBRAB9A
SCHEMBL975145 0.87 PARP10 (0.54) PARP10MAPTKDM4EPOLBRAB9A
SCHEMBL974397 0.87 PARP10 (0.54) PARP10MAPTKDM4EPOLBRAB9A
SCHEMBL2248223 0.87 ALOX5AP (0.55) PARP10MAPTKDM4EPOLBRAB9A
SCHEMBL978458 0.86 PARP10 (0.53) PARP10MAPTKDM4EPOLBRAB9A
SCHEMBL1122619 0.86 MAPT (0.64) PARP10MAPTKDM4EPOLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4161494-A1 NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS KSQ Therapeutics, Inc. (US) 2023-04-12 EP disclosed